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A mammalian 2-5A system functions as an antiviral pathway in
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ABSTRACT Resistance to virus infections in higher ver-
tebrates is mediated in part through catalysis of RNA decay
by the interferon-regulated 2-5A system. A functional 2-5A
system requires two enzymes, a 2-5A synthetase that produces
5"phosphorylated, 2',5'-linked oligoadenylates (2-5A) in re-
sponse to double-stranded RNA, and the 2-5A-dependent
RNase L. We have coexpressed these human enzymes in
transgenic tobacco plants by using a single plasmid contain-
ing the cDNAs for both human RNase L and a low molecular
weight form of human 2-5A synthetase under control of
different, constitutive promoters. Expression of the human
cDNAs in the transgenic plants was demonstrated from
Northern blots, by specific enzyme assays, and by immuno-
detection (for RNase L). Infection of leaves, detached or in
planta, of the coexpressing transgenic plants by tobacco
mosaic virus, alfafa mosaic virus, or tobacco etch virus
resulted in necrotic lesions. In contrast, leaves expressing
2-5A synthetase or RNase L alone and leaves containing the
plasmid vector alone produced typical systemic infections.
While alfalfa mosaic virus produced lesions only in the
inoculated leaves regardless of the concentration of virus in
the inoculum, high, but not low, levels of tobacco etch virus
inoculum resulted in escape of virus to uninoculated leaves.
Nevertheless, there was a substantial reduction of tobacco
etch virus yield as measured by ELISA assay in the coexpress-
ing transgenic plants. These results indicate that expression of
a mammalian 2-5A system in plants provides resistance to
virus infections.
The interferon family of cytokines induces an antiviral state in
cells of higher vertebrates (1). Virus-infected cells produce and
secrete interferons a and f3, which signal uninfected cells that
a virus infection has occurred. Interferons bind to specific cell
surface receptors, activating Jak-STAT signal transduction
pathways that induce interferon-stimulated genes (2). The
proteins encoded by these genes are responsible for the
biological effects of interferons, including the antiviral re-
sponses. The 2-SA system (3) is one such interferon-induced
antiviral pathway present in cells of reptiles, avians, and
mammals (4). Two types of enzymes are essential for a
functional 2-SA system: (i) any one of several 2-SA synthetases,
which require double-stranded (dsRNA) to produce 2-SA, a
series of 5'-phosphorylated, 2',5'-linked oligoadenylates (5, 6)
and (ii) the 2-SA-dependent RNase L (7-9). 2-SA activates
RNase L which cleaves viral and cellular single-stranded
RNAs, predominantly after UpNp sequences (10, 11). Because
virus-infected cells often contain dsRNA activators of 2-SA
synthetase (12), for instance as replicative intermediates of
RNA viruses, RNA degradation by RNase L frequently occurs
in interferon-treated virus-infected cells (13, 14). It is well
established that the 2-5A system inhibits replication of the
picornaviruses, encephalomyocarditis virus, and mengo virus
in interferon-treated mammalian cells (15-18).
Plants appear to lack an equivalent of the mammalian 2-5A
system. Kerr and colleagues (4) could not detect RNase L,
assayed by 2-SA binding activity, in tobacco, Nicotiana gluti-
nosa and Nicotiana tabacum. Furthermore, in the same study,
no 2-5A synthetase was detected nor was any 2-5A detected in
control, tobacco mosaic virus (TMV)-infected, interferon-
treated or poly(I).poly(C)-treated plants. The absence of a
2-SA system in control tobacco plants is verified in this study
(Figs. 2-5). Previously, expression in potato of rat 2-SA
synthetase mRNA, without coexpression of RNase L, was
correlated with partial resistance to potato virus X in some but
not all transgenic plants (19). The biochemical basis for both
this effect and for an anti-TMV effect of 2',5'-oligoadenylate
in nontransgenic N. glutinosa leaf disks was not established
(20). Although plant oligoadenylates do exist, they differ
substantially from 2-SA (21). Accordingly, the present work
was undertaken to genetically engineer virus-resistant plants
by expression of a mammalian 2-SA system consisting of both
2-SA synthetase and RNase L.
MATERIALS AND METHODS
Construction of the Expression Vector and Transformation
of Plants. The coding regions for a low molecular weight (40
kDa) species of human 2-SA synthetase and for human RNase
L were obtained from plasmids pBabe.E1.6S (a gift from
B. R. G. Williams, The Cleveland Clinic Foundation) and
pZC5 (9), respectively. Coexpression of these cDNAs was
engineered by subcloning into the binary (22) plant transfor-
mation/expression vector, pAM2200. This construct con-
tained a 1321 bp EcoRI fragment of 2-SA synthetase cDNA
and a 2249-bp HindIII fragment of RNase L cDNA, each
containing the complete coding sequences. Both the fragments
were modified by PCR to contain a GCCACC sequence
immediately preceding to the ATG translation start site to
provide a better context for plant cell translation. In addition,
2-5A synthetase contained an additional GGG codon after the
ATG codon. The inserted fragments were partially sequenced
across the junctions to confirm proper fusion of the fragments.
The binary plasmid also contained a neomycin phosphotrans-
ferase plant selectable marker gene driven by the transferred
DNA (T-DNA) gene nopaline synthase promoter (23). This
plasmid was used to produce transgenic tobacco plants by
Agrobacterium-mediated transformation of axenically grown
tobacco seedlings (24). Transformed tobacco plants were
selected on Murasighe & Skoog (MS) (25) plates containing
300 jig of kanamycin per ml.
Abbreviations: dsRNA, double-stranded RNA; TMV, tobacco mosaic
virus; TEV, tobacco etch virus; AIMV, alfalfa mosaic virus.
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Southern and Northern Blots of Plants Detect Integration
and Expression of the Transgenes. Integration of the plasmid
DNA into plant DNA was determined by Southern blot
analysis (26). Five grams of fresh plant tissue was used to
prepare DNA as described by Guillemaut and Mar6chal-
Drouard (27). Briefly, plant tissue was ground in liquid
nitrogen and thawed in extraction buffer (100 mM sodium
acetate, pH 4.8/50 mM EDTA, pH 8.0/500 mM NaCl/2%
polyvinylpyrrolidone-40; the mixture adjusted to pH 5.5, then
SDS was added to 1.4% and cysteine to 10 mM), incubated at
65°C for 20 min and centrifuged. One-half volume of 3 M
potassium acetate (pH 4.8) was added to the supernatant, and
the mixture was incubated at 0°C for 1 h. The DNA was
recovered by ethanol precipitation, dissolved in TE buffer, and
centrifuged overnight in a cesium chloride gradient. DNA was
digested with Hindlll, separated on a 1% agarose gel, and
transferred to a Zeta-probe membrane (Bio-Rad) according to
the manufacturer's recommendations. The membrane was
hybridized with a randomly labeled DNA probe (28) by using
the human 2-5A synthetase and RNase L cDNAs as templates.
To determine expression of 2-SA synthetase and RNase L
cDNAs in transgenic tobacco plants, total RNA was prepared
from 15 independently transformed plants as described by
Logemann et al. (29). RNA extraction buffer contained 8 M
guanidinium chloride, 20 mM Mes, 20 mM EDTA, and 50 mM
2-mercaptoethanol (pH 7.0). Aliquots of RNA samples were
separated on formaldehyde gels, transferred to the Zeta-probe
membranes and probed with the same radiolabeled DNA
fragments as in the Southern blots.
Detection of RNase L Protein by Western Blot. A total
cellular extract was prepared by grinding transformed plant
tissue in liquid nitrogen and thawing in protein extraction
buffer (0.5 M sucrose/0.1% ascorbic acid/0.1% cysteine-HCl/
0.01 M Tris-HCl, pH 7.5) (23) in the presence of 15 jig
phenylmethylsulfonyl fluoride. The homogenate was centri-
fuged at 14,000 x g for 30 min at 4°C, and the supernatant
containing the soluble proteins was recovered and concen-
trated using a Microcon (Amicon) concentrator. Extracts (200
,ug of protein) were separated on a 12.5% acrylamide gel (30)
along with 200 ng recombinant RNase L protein as a standard.
The resolved proteins were transferred to a nitrocellulose
membrane using a Bio-Rad trans-blot apparatus at 250 mA for
1 h. The membrane was immersed in a blocking solution (5%
nonfat dry milk in Tris-buffered saline) and incubated at 28°C
for 1 h. The membrane was then washed and incubated with
a 1:5000 dilution of a mouse monoclonal antibody prepared
against human RNase L antigen (49). Following incubation
with the antibody, the membrane was placed in the biotinylated
goat anti-mouse antibody solution for 1 h at 28°C with gentle
agitation. The membrane was washed and incubated in a
streptavidin-biotinylated alkaline phosphatase complex for 1 h
followed by immersion in a color development solution until
purple bands became visible.
Determination of RNase L Activity in Intact Leaves. Leaves
from plants expressing both or one of the cDNAs and control
leaves were injected with 2-SA [2.5 ,uM p3A(2'pS'A)3 in 12.5
p.M phosphate buffer, pH 6.8] by using a fine needle (22 or 26
gauge; Becton Dickinson) attached to a tuberculin syringe.
The injection was carried out by inserting the needle into leaf
tissue close to a vein and injecting the solution until a part of
lamina appeared water-soaked. This process was repeated
several times until the entire leaf was infiltrated with the
solution. Presence of the solution in the intercellular spaces of
leaf tissue could be readily detected by the water-soaked
appearence of the leaf tissue. Because of leakage at the
injection sites, it was not possible to determine exact amount
of the solution that was retained in each leaf. However, the
entire leaf was saturated with the solution by filling up
intercellular spaces. Leaves were harvested 3 h after the
injections and were frozen immediately in liquid nitrogen.
Total RNA was prepared from the frozen leaves as described
above, fractionated on a formaldehyde-agarose gel, and trans-
ferred to a membrane. The RNA in the blots was hybridized
to a 32P-labeled human 18S rRNA cDNA probe (18) (a gift of
Bret A. Hassel, Baltimore).
Assay of 2-5A Synthetase Activity in Extracts of Leaves.
Plant extracts were prepared by homogenizing leaves in Non-
idet P-40 lysis buffer [0.5% (vol/vol) Nonidet P-40/90 mM
KCl/5 mM magnesium acetate/20 mM Tris-HCl, pH 7.5/5
mM 2-mercaptoethanol/10 p,g of leupeptin per ml]. Cell
lysates were centrifuged at 10,000 x g for 10 min at 4°C, the
supernatants were collected, and the protein concentration
was determined as described (32). Extracts of interferon-
treated (200 units per ml human interferon a for 18 h) human
HeLa cells were prepared by the same method, except cells
were disrupted by vortex mixing. 2-SA synthetase in the cell
and leave extracts were adsorbed to the activating affinity
matrix, poly(I).poly(C) cellulose as described (33, 34).
Poly(I).poly(C) covalently linked to cellulose was washed three
times in buffer A [20 mM Tris-HCl, pH 7.5/50 mM KCl/5 mM
magnesium acetate/5 mM mercaptoethanol/10% (vol/vol)
glycerol]. Protein extract from the leaves or HeLa cells, 200 ,ug
per assay, was incubated with 11 ,ug poly(I)-poly(C) linked to
cellulose in a final volume of 60 ,ul for 1 h on ice. After washing
three times in buffer A by vortex mixing, centrifugation, and
resuspension, the pellet was suspended in buffer A supple-
mented with 8 mM ATP and 16 mM magnesium chloride and
incubated at 30°C for 24 h. After centrifugation, the superna-
tant was removed and assayed for 2-5A.
To measure 2-SA, the supernatants (5 ,ul each) or known
amounts of authentic pA(2'p5'A)3 were incubated in a final
volume of 25 ,ul with insect extract containing human, recom-
binant RNase L (31) (1 jig per assay) in the presence of 0.2mM
poly(U) labeled at the 3' termini with [32P]pCp (3000 Ci/
mmol; 1 Ci = 37 GBq) and T4 RNA ligase as described (35).
Reactions were performed at 30°C for 30 min in 20 mM
Tris HCl (pH 7.5), 10 mM magnesium acetate, 8 mM 2-mer-
captoethanol, 90 mM KCl, and 10 ,ug of leupeptin per ml.
Reactions were terminated with 5 ,ul stop buffer, boiled for 5
min, centrifuged briefly, and S ,ul was loaded to 6% polyacryl-
amide/8 M urea gels. After electrophoresis, x-ray film was
exposed to the gel.
Virus Inoculation of Plants. Transgenic plants were grown
in an access-controlled greenhouse. Rl transgenic plants were
examined for virus resistance by using both cut-leaf and in
planta inoculation assays. Leaves from these plants were cut at
the petiole and placed in Petri dishes on moist filter papers.
Leaves maintained in Petri dishes for the incubation period
remained in good physiological condition. The leaves were
inoculated with a 1:100, 1:1000, and 1:2500 dilution of freshly
prepared extracts from tobacco leaves systemically infected
with tobacco etch virus (TEV, severe strain; ATCC PV69),
TMV (common strain), and alfalfa mosaic virus (AlMV,
Nebraska strain) respectively. Six of six control plants became
systemically infected when inoculated with sap diluted
1:10,000, 1:100,000, and 1:150,000, respectively. Following
inoculation with virus, the leaves were rinsed with water, and
Petri dishes sealed with stretched parafilm and placed in an
incubator at 22°C for 7 days under 18-h light per day. In planta
inoculation of greenhouse grown transgenic plants were car-
ried out by using various dilutions of TEV and AIMV. A total
of 33 and 29 kanamycin resistant transgenic plants were
inoculated with TEV and AIMV, respectively. A single leafwas
inoculated in each plant by using either TEV or AIMV. Virus
titers in the TEV-inoculated and in upper uninoculated leaves
were determined by ELISA by using TEV-specific polyclonal
antibodies and purified TEV virions to construct standard
curves (36). TEV antibodies were prepared in rabbit by using
TEV virions as antigen.
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FIG. 1. Subcloning, integration, and expression in plants of transgenes. A partial map of the expression plasmid containing cDNAs to a human
form of 2-5A synthetase and human RNase L is shown. P35S and Pamt, cauliflower mosaic virus 35S and chlorella virus adenine methyltransferase
gene promoters; T35S and T7', terminators from cauliflower mosaic virus 35S and T-DNA transcript 7.
RESULTS
Construction of Transgenic Plants Expressing Human
RNase L and 2-5A Synthetase. To express a human 2-5A
system in plants, a binary plant transformation-expression
vector containing both the 2-5A synthetase and RNase L
cDNAs under control of the cauliflower mosaic virus 35S
promoter (37) and the chlorella virus adenine methyltrans-
ferase gene promoter (38), respectively, was constructed (Fig.
1). Young tobacco seedlings (N. tabacum, petit Havana SR-1)
(39) were transformed by using the Agrobacterium cocultiva-
tion method (24). Cloning of the human 2-5A system cDNAs
in these plants had no effect on the transformation frequency,
growth, or development of the plants. All of the primary
transformants (RO) that were grown to maturity and allowed
to self-pollinate produced viable seeds. Kanamycin-resistant
Ri seedlings were grown in a greenhouse and analyzed for
transgene expression and virus resistance. Southern blot anal-
ysis of the transgenic plants showed that most of the kanamy-
cin-resistant plants contained intact and unmodified inserts
(Fig. 2A), indicating appropriate integration of the transgenes
into plant chromosomes. However, one plant was observed to
contain only the 2-5A synthetase cDNA and another plant
contained only the RNase L cDNA (Fig. 2A, lanes 6 and 7,
respectively). Northern blot analysis indicated that both the
2-5A synthetase and RNase L transgenes were transcribed in
the transformed plants (Fig. 2B). RNA from the control
tobacco plants containing the empty plasmid vector did not
hybridize to either the 2-5A synthetase or RNase L radiola-
beled cDNA probes (Fig. 2B, lane 1).
Production of Functional RNase L in the Transgenic Plants.
The expression of RNase L in transgenic tobacco was moni-
tored by probing Western blots with a monoclonal antibody to
human RNase L (49). All transgenic plants expressing RNase
L mRNA also expressed the nuclease protein (Fig. 3). RNase
L comigrating with authentic human, recombinant RNase L
(lane RL) was observed in plants containing both the syn-
thetase and RNase L cDNAs (lanes 3-5) as well as in plants
containing only the RNase L cDNA (lane 2) but not in plants
containing the empty plasmid vector (lane C). The immuno-
blot showed a single protein band of about 80 kDa in protein
extracts from transgenic plants.
To determine if the RNase L in the transgenic tobacco
plants was functional, the integrity of the 18S rRNA was
analyzed after injecting detached leaves with 2-5A (Fig. 4).
Transgenic leaves were injected with 2.5 ,uM p3A(2'p5'A)3 and
then incubated for 3 h before total RNA was prepared.
Degradation of rRNA was demonstrated by probing the total
RNA on a Northern blot with a radiolabeled cDNA to 18S
rRNA. Injection of 2-5A resulted in enhanced degradation of
rRNA in transgenic plants expressing both the 2-5A synthetase
and RNase L (lane 6) or only RNase L (lane 5), but not in
control plants transformed with vector alone (lane 1) or in
plants expressing only 2-5A synthetase (lane 3). In addition,
specific 2-5A binding activity was detected in transgenic plants
expressing RNase L but not in control plants (data not shown).
These data indicate that introduction of the human RNase L
cDNA into transgenic plants led to production of a functional
RNase L enzyme. Because of the requirement for dsRNA to
activate 2-5A synthetase, coexpression of RNase L and 2-5A
A SYN
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FIG. 2. (A) Southern blot of DNA from control and transgenic
plants. Numbers at right are size markers in kbp. (B) Northern blot
analysis ofRNA isolated from control and transgenic plants. Lanes: 1,
control tobacco plant containing empty plasmid vector; 2-5, trans-
genic plants containing both 2-5A synthetase and RNase L cDNAs; 6,
transgenic plant containing 2-5A synthetase cDNA only; 7, transgenic
plant containing RNase L cDNA only. SYN, 2-5A synthetase; RL,
RNase L.
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FIG. 3. Immunodetection of RNase L in transgenic plants with a
monoclonal antibody to human RNase L. Numbers at right are protein
size markers in kDa. Lanes: RL, recombinant human RNase L protein
(200 ng); C, protein extract from control tobacco plant containing
empty plasmid vector; 1-5, protein extracts from transgenic tobacco
plants; 1, transgenic plants containing only 2-5A synthetase cDNA; 2,
transgenic plant containing only RNase L cDNA; 3-5, plants contain-
ing both 2-SA synthetase and RNase L cDNAs.
synthetase, by itself, apparently does not lead to activation of
RNase L, at least not to the extent that it can be measured by
this assay.
Expression ofFunctional 2-5A Synthetase in the Transgenic
Plants. To determine if 2-5A synthetase was present in the
transgenic tobacco plants, we performed functional assays for
this enzyme. A lack of a high affinity antibody for human
40-kDa 2-5A synthetase precluded Western blot assays for this
protein. 2-SA synthetase in extracts of leaves or in interferon-
treated human HeLa cells was immobilized and activated by
using the affinity matrix, poly(I)-poly(C)-cellulose (see Mate-
rials and Methods) (33, 34). Production of 2-5A oligonucleo-
tides from ATP was then determined by the ability to activate
recombinant human RNase L (31) (Fig. 5). For comparison,
authentic 2-5A [pA(2'p5'A)3] was incubated with RNase L,
resulting in the production of discrete poly(U) cleavage prod-
ucts (lanes 1-6). Partial cleavage of poly(U) was induced with
0.3 nM 2-5A, with maximal breakdown of poly(U) occurring at
a concentration of 7 nM 2-5A. Control plants lacked detectable
2-5A synthetase activity, in accord with a previous report
(lanes 7 and 8) (4). In contrast, 2-SA synthetase was clearly
obtained in plants containing human 2-5A synthetase cDNA
(lanes 9 and 10 are from a plant transgenic for both human

















FIG. 4. 2-SA induced degradation of rRNA in transgenic plants
expressing RNase L protein. Leaves were injected with 2.5 p,M 2-SA
(lanes 1, 3, 5, and 6), total RNA was extracted after 3 h, and probed
with 32P-labeled 18S cDNA. Lanes 1 and 2, control plant; lanes 3-and
4, plant expressing only 2-5A synthetase (Syn); lane 5, plant expressing
only RNase L (RL); lanes 6 and 7, plants expressing both 2-SA
synthetase and RNase L (Syn+RL).
1 2 3 43 b6 d 9 1U 11 12
RNase L: + + + + + + + - + - + -
2-5A, nM: O .3 1 7 1 3 33 Control Trans. IFN/HeLa2-5A, nM:0.3 1 7 13
~
Plant Plant
FIG. 5. Transgenic plants produce functional, human recombinant
2-SA synthetase. Lanes 1-6 show activation of RNase L by authentic
pA(2'p5'A)3. Extracts of control plants with empty vector (lanes 7 and
8), plants containing cDNA to both human RNase L and 2-SA
synthetase (lanes 9 and 10), and extract of interferon (IFN)-treated
human HeLa cells (lanes 11 and 12) were assayed for 2-SA synthetase
activity. 2-SA was assayed by its ability to activate RNase L (added in
lanes 1-7, 9, and 11) to cleave poly (U) to discrete products (arrows).
An autoradiogram of the sequencing gel is shown.
products were observed with authentic 2-5A (lanes 1-6), the
transgenic plants (lane 9), and with 2-5A synthetase assays
from interferon-treated human HeLa cells (lanes 11 and 12).
In every instance, the cleavage of poly(U) required the addi-
tion of RNase L, thus ruling out the possibility that the
breakdown of the RNA was due to contaminating ribonucle-
ases. These results demonstrated production of nanomolar
levels of functional 2-SA in synthetase assays performed on
extract of the transgenic tobacco plants. Although these
amounts of 2-5A are very low, they were more than sufficient
to activate RNase L (Fig. 5, lane 9).
Coexpression of Human 2-5A Synthetase and RNase L
Produces Antiviral Effects in Intact Tobacco Plants. To
monitor viral resistance, leaves were manually inoculated with
three different types of plant viruses: TEV, a member of the
potyvirus group; TMV, a member of the tobamovirus group;
and AIMV, a member of the bromovirus group (40). Leaves
from a total of 48 kanamycin-resistant Rl progeny plants
expressing both 2-SA synthetase and RNase L, or either
proteins alone, were tested. A composite picture from repre-
sentative plants is shown (Fig. 6). Infection of plants expressing
both proteins induced necrotic local lesions (Fig. 6 a, c, and e),
in contrast plants expressing only 2-5A synthetase (Fig. 6g),
only RNase L (Fig. 6h) and control plants containing the
empty plasmid vector (Fig. 6 b, d, and f) produced typical
systemic infections. In nature, TEV and AIMV are not known
to produce local lesions in tobacco plants (40). TMV does
Plant Biology: Mitra et al.






FIG. 6. Virus-inoculated leaves showing local lesions. Leaves from
transgenic or control plants were mechanically inoculated with either
TEV, TMV, or AIMV. (a, c, e) Plants expressing both 2-5A synthetase
and RNase L. (g) Plant expressing 2-5A synthetase alone. (h) Plant
expressing RNase L alone. Controls plants (b, d and f) are transgenic
for the vector-alone construct.
produce local lesions in tobacco plants containing the N or N'
gene (41). However, the tobacco cultivar that was used for
current experiments (SR-1) does not contain the N gene and
hence is a systemic host for TMV. The necrotic lesions
produced by different viruses were morphologically distinct. In
addition, lesions produced by AIMV were smaller than those
of TEV and TMV. Lesions in transgenic plants appeared
quickly, within 48 h, whereas TMV lesions in hypersensitive
control plants (N. tabacum, var Samsun NN and Xanthi nc)
appeared only after 72 h. There was a direct correlation
between the inoculum concentrations and number of local
lesions. To ascertain that virus in transgenic tobacco plants
expressing the human 2-SA system did not undergo alteration
or mutation, virus was recovered from single lesions and
reinoculated onto control plants. All three recovered viruses
produced typical symptoms and systemic infection in control
plants.
In planta inoculation of kanamycin resistant Ri and R2
seedlings with TEV and AIMV also produced lesions in the
inoculated leaves, despite a decline in expression of 2-5A
synthetase and RNase L in the R2 as compared to the Ri
generations of transgenic plants (data not shown). However,
when high levels of TEV inoculum (causing >100 lesions per
leaf) were used, the inoculated leaves showed veinal necrosis
and necrotic lines extended from leaf veins to petioles and then
to stems in the inoculated leaves through veins to mostly upper
but sometimes both upper and lower parts of the plants.
Therefore, TEV virions escaped into vascular tissues from
inoculated tissue when a high concentration inoculum was
used. In planta infection by TMV had similar effects as TEV.
Despite the escape of TEV from inoculated leaves, there was
nevertheless a substantial antiviral effect in the transgenic
plants. Quantitation of TEV production by an ELISA showed
a significant antiviral effect in the R2 generation of co-
expressing transgenic plants (Table 1). There was a 5- to
15-fold reduction of TEV production in the inoculated leaves
and 16- to 35-fold reduction in the uninoculated upper leaves
in comparison to infected control plants containing the empty
plasmid vector. Data indicated the presence of virus only in the
necrotic tissue but not in other areas (Table 1). However, at
low levels of TEV inoculum, there was a 16- to 23-fold
reduction in virus production in the inoculated leaves with no
escape to upper leaves. In contrast to results obtained with
TEV, no systemic symptoms were found in transgenic plants
infected with AIMV, even 40 days after inoculation. In addi-
tion, AIMV infection of the coexpressing transgenic plants
produced only local lesions and only on the inoculated leaves
without veinal necrosis, even when high levels of inoculum
(>500 lesions/leaf) was used (data not shown). Therefore, a
substantial antiviral effect was retained in the R2 generation
of coexpressing transgenic plants.
DISCUSSION
Results present here provide a clear, visual demonstration that
the expression of a mammalian 2-5A system restricts viral
replication in transgenic plants. Although we show that coex-
pression of the two proteins, 2-SA synthetase and RNase L, is
required for the formation of local lesions, the precise mech-
anism of action for the antiviral effect in plants remains to be
elucidated. The most likely interpretation of these data is that
viral dsRNAs activated the 2-SA synthetase resulting in RNA
decay by RNase L thus limiting viral replication. Apparently,
the very low levels of expression of these proteins, compared
Table 1. ELISA determination of TEV titer in
virus-inoculated plants
TEV concentrations, ,g/g fresh tissue
Uninoculated
Inoculated leaves upper leaves
Necrotic Nonnecrotic Necrotic Nonnecrotic
Plants tissuet tissue tissuet tissue
High Inoculum (1:100 dilution, >100 lesions/leaf)
1 8.62 0.35 2.22 0.38
2 3.37 0.45 3.81 0.44
3 9.51 0.2-2 1.72 0.28
4 4.12 0.31 2.86 0.37
5 7.13 0.33 3.53 0.35
C 52.24 61.11
Low Inoculum (1:2000 dilution, <5 lesions/leaf)
1 2.55 0.31 t 0.22
2 3.26 0.38 - 0.30
3 2.71 0.22 -t 0.25
4 2.32 0.28 -t 0.32
5 2.78 0.31 - 0.36
C 53.38 -: 52.57
Plants 1-5, independently transformed kanamycin-resistant trans-
genic plants; C, control plants containing empty plasmid vector.
*Virus concentrations were determined 21 days after inoculation by
ELISA without background correction by using standard curves
constructed from purified viruses. A minimum of four leaves was
assayed from each transgenic plants, and each sample was run in
duplicate.
tNecrotic tissue contained both lesion and nonlesion areas.
tNo necrotic tissue.
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for instance to interferon-treated, human cells, was sufficient
to produce an antiviral response. Activation of the 2-5A system
in plants could conceivably be achieved either by extensive
secondary structure in viral RNAs or by double-stranded
replicative intermediates formed during viral replication. With
low, but not high, inoculums of TEV, and with both low and
high inoculums of AIMV, there were lesions only on initially
infected leaves. However, at high inoculums of TEV, virus
escape occurred into the vascular system with translocation of
virus to other parts of the plants. In either case, there was
destruction of cells in vascular bundles and other tissues.
Expression of the 2-5A system substantially reduced viral
growth, even when plants were inoculated with high amounts
ofTEV (Table 1). We therefore conclude that the viruses used
in this study caused the destruction of the infected cells in the
coexpressing transgenic plants, leading to the formation of
necrotic lesions and the observed antiviral effects.
Expression of the 2-5A system in plants has several apparent
advantages compared to alternative plant antiviral strategies
currently in use. The most common approach involves patho-
gen-derived resistance (42) in which plants are transformed to
express certain viral-coded proteins or antisense RNAs (43,
44). A potential limitation of this approach has been virus
recombination that may occur in transgenic plants and might
yield a more virulent virus, expansion of the host range of a
virus or vector specificity (45-47). These risks, in general, are
not considered to be high (48). However, even in instances of
substantial resistance to virus infection, protection is usually
limited to the virus from which the protein or antisense RNA
was derived, or to closely related strains. In contrast, the 2-5A
system is predicted to provide resistance to any plant virus that
produces dsRNA in the infected cell. Most plant viruses,
including those in the economically important potyvirus
group, are positive sense, single-stranded RNA viruses which
produce a dsRNA intermediate during their replicative pro-
cess. Furthermore, because plant viruses are naive to the 2-5A
system, they are likely to be even more vulnerable to it than
viruses of higher vertebrates.
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